Literature DB >> 15340065

A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia.

Mayumi Jijiwa1, Toshifumi Fukuda, Kumi Kawai, Akari Nakamura, Kei Kurokawa, Yoshiki Murakumo, Masatoshi Ichihara, Masahide Takahashi.   

Abstract

The Ret receptor tyrosine kinase plays a crucial role in the development of the enteric nervous system and the kidney. Tyrosine 1062 in Ret represents a binding site for the phosphotyrosine-binding domains of several adaptor and effector proteins that are important for the activation of intracellular signaling pathways, such as the RAS/ERK, phosphatidylinositol 3-kinase/AKT, and Jun-associated N-terminal kinase pathways. To investigate the importance of tyrosine 1062 for organogenesis in vivo, knock-in mice in which tyrosine 1062 in Ret was replaced with phenylalanine were generated. Although homozygous knock-in mice were born normally, they died by day 27 after birth and showed growth retardation. The development of the enteric nervous system was severely impaired in homozygous mutant mice, about 40% of which lacked enteric neurons in the whole intestinal tract, as observed in Ret-deficient mice. The rest of the mutant mice developed enteric neurons in the intestine to various extents, although the size and number of ganglion cells were significantly reduced. Unlike Ret-deficient mice, a small kidney developed in all knock-in mice, accompanying a slight histological change. The reduction of kidney size was due to a decrease of ureteric bud branching during embryogenesis. Thus, these findings demonstrated that the signal via tyrosine 1062 plays an important role in histogenesis of the enteric nervous system and nephrogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340065      PMCID: PMC515068          DOI: 10.1128/MCB.24.18.8026-8036.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Defects in enteric innervation and kidney development in mice lacking GDNF.

Authors:  J G Pichel; L Shen; H Z Sheng; A C Granholm; J Drago; A Grinberg; E J Lee; S P Huang; M Saarma; B J Hoffer; H Sariola; H Westphal
Journal:  Nature       Date:  1996-07-04       Impact factor: 49.962

2.  Renal agenesis and the absence of enteric neurons in mice lacking GDNF.

Authors:  M P Sánchez; I Silos-Santiago; J Frisén; B He; S A Lira; M Barbacid
Journal:  Nature       Date:  1996-07-04       Impact factor: 49.962

3.  Renal and neuronal abnormalities in mice lacking GDNF.

Authors:  M W Moore; R D Klein; I Fariñas; H Sauer; M Armanini; H Phillips; L F Reichardt; A M Ryan; K Carver-Moore; A Rosenthal
Journal:  Nature       Date:  1996-07-04       Impact factor: 49.962

4.  Molecular heterogeneity of RET loss of function in Hirschsprung's disease.

Authors:  F Carlomagno; G De Vita; M T Berlingieri; V de Franciscis; R M Melillo; V Colantuoni; M H Kraus; P P Di Fiore; A Fusco; M Santoro
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

5.  Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase.

Authors:  Ming-Jer Tang; Yi Cai; Si-Jie Tsai; Yang-Kao Wang; Gregory R Dressler
Journal:  Dev Biol       Date:  2002-03-01       Impact factor: 3.582

6.  The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.

Authors:  M G Borrello; L Alberti; E Arighi; I Bongarzone; C Battistini; A Bardelli; B Pasini; C Piutti; M G Rizzetti; P Mondellini; M T Radice; M A Pierotti
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

Review 7.  The GDNF family: signalling, biological functions and therapeutic value.

Authors:  Matti S Airaksinen; Mart Saarma
Journal:  Nat Rev Neurosci       Date:  2002-05       Impact factor: 34.870

8.  Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.

Authors:  O Geneste; C Bidaud; G De Vita; R M Hofstra; S Tartare-Deckert; C H Buys; G M Lenoir; M Santoro; M Billaud
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

9.  The role of amino acids surrounding tyrosine 1062 in ret in specific binding of the shc phosphotyrosine-binding domain.

Authors:  Y Ishiguro; T Iwashita; H Murakami; N Asai; K Iida; H Goto; T Hayakawa; M Takahashi
Journal:  Endocrinology       Date:  1999-09       Impact factor: 4.736

10.  Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development.

Authors:  A Schuchardt; V D'Agati; V Pachnis; F Costantini
Journal:  Development       Date:  1996-06       Impact factor: 6.868

View more
  49 in total

Review 1.  Total colonic aganglionosis and Hirschsprung's disease: a review.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2014-10-31       Impact factor: 1.827

2.  The many faces of RET dysfunction in kidney.

Authors:  Sanjay Jain
Journal:  Organogenesis       Date:  2009-10       Impact factor: 2.500

3.  Identification of a key motif that determines the differential surface levels of RET and TrkB tyrosine kinase receptors and controls depolarization enhanced RET surface insertion.

Authors:  Xue-Zhi Li; Jing Yan; Shu-Hong Huang; Ling Zhao; Jue Wang; Zhe-Yu Chen
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

Review 4.  To bud or not to bud: the RET perspective in CAKUT.

Authors:  T Keefe Davis; Masato Hoshi; Sanjay Jain
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

Review 5.  Medullary thyroid cancer: monitoring and therapy.

Authors:  Douglas W Ball
Journal:  Endocrinol Metab Clin North Am       Date:  2007-09       Impact factor: 4.741

6.  A common RET variant is associated with reduced newborn kidney size and function.

Authors:  Zhao Zhang; Jackie Quinlan; Wendy Hoy; Michael D Hughson; Mathieu Lemire; Thomas Hudson; Pierre-Alain Hueber; Alice Benjamin; Anne Roy; Elena Pascuet; Meigan Goodyer; Chandhana Raju; Fiona Houghton; John Bertram; Paul Goodyer
Journal:  J Am Soc Nephrol       Date:  2008-10       Impact factor: 10.121

7.  Loss of Sprouty1 rescues renal agenesis caused by Ret mutation.

Authors:  Esteban J Rozen; Hagen Schmidt; Xavier Dolcet; M Albert Basson; Sanjay Jain; Mario Encinas
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

8.  Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis.

Authors:  Benson C Lu; Cristina Cebrian; Xuan Chi; Satu Kuure; Richard Kuo; Carlton M Bates; Silvia Arber; John Hassell; Lesley MacNeil; Masato Hoshi; Sanjay Jain; Naoya Asai; Masahide Takahashi; Kai M Schmidt-Ott; Jonathan Barasch; Vivette D'Agati; Frank Costantini
Journal:  Nat Genet       Date:  2009-11-08       Impact factor: 38.330

9.  Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model.

Authors:  Takayoshi Fujibayashi; Naozumi Hashimoto; Mayumi Jijiwa; Yoshinori Hasegawa; Toshihisa Kojima; Naoki Ishiguro
Journal:  BMC Pulm Med       Date:  2009-09-16       Impact factor: 3.317

10.  Histochemical analysis of renal dysplasia with ureteral atresia.

Authors:  Toyoko Kawate; Ryuki Kawamura; Takenori Uchida; Kyosuke Takahashi; Tomohiro Hasegawa; Haruo Futamata; Ryohei Katoh; Sen Takeda
Journal:  Acta Histochem Cytochem       Date:  2009-04-25       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.